Literature DB >> 17237958

[Risk factors for intra- and postoperative complications in Wilms' tumor surgery].

V Zugor1, D Krot, G E Schott.   

Abstract

BACKGROUND: Wilms' tumor is the most common renal tumor in childhood. Preoperative treatment is still under discussion. The aim of this study was to determine, using our own patient collective, the risk factors for and type of intraoperative complications which can occur. In addition, the influence of the surgical procedure and tumor size on the complications and survival rate was analyzed. METHODS AND MATERIALS: A total of 66 patients with Wilms' tumor were retrospectively analyzed. Evaluation included histology, size of the primary tumor as well as neoadjuvant and adjuvant chemotherapy. The total survival rate over periods of 5 and 10 years postoperatively were analysed using Kaplan-Meier survival probabilities.
RESULTS: All patients underwent radical nephrectomy: 63 using the transperitoneal and three the lumbar approach. The tumors had a mean size of 9.8 cm (range 2.5-20.0). Twenty patients (30.3%) received neoadjuvant chemotherapy for tumor reduction, while 46 patients underwent surgery without preoperative chemotherapy. Complications occurred in eight patients (15.2%). In two, a the tumor ruptured under surgery, four patients developed an ileus and two suffered cardiac arrest. One patient had postoperative hypertonia and another an incisional hernia. All complications occurred with a tumor size >5 cm or in the patient group without neoadjuvant chemotherapy. The 10 year survival rate was 89.4%.
CONCLUSIONS: The risk of complications is associated with the local size of the primary tumor. Through tumor reduction, neoadjuvant chemotherapy influences the expression of the such complications. Transperitoneal tumor nephrectomy is the method of choice in surgery for Wilms' tumors.

Entities:  

Mesh:

Year:  2007        PMID: 17237958     DOI: 10.1007/s00120-006-1287-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  17 in total

1.  Cavectomy for the treatment of Wilms tumor with vascular extension.

Authors:  Rodrigo Chaves Ribeiro; Sergio Tomaz Schettini; Simone de Campos Vieira Abib; José Honório Palma da Fonseca; Mônica Cypriano; Nasjla Saba da Silva
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

2.  The surgical treatment of Wilms' tumor: results of the National Wilms' Tumor Study.

Authors:  L L Leape; N E Breslow; H C Bishop
Journal:  Ann Surg       Date:  1978-04       Impact factor: 12.969

Review 3.  Wilm's tumor: an update.

Authors:  G J D'Angio; J B Beckwith; N E Breslow; H C Bishop; A E Evans; V Farewell; D Fernbach; W E Goodwin; B Jones; L L Leape; N F Palmer; M Tefft; J A Wolff
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

Review 4.  Extrarenal adult Wilms' tumor.

Authors:  M J Koretz; S Wang; F A Klein; W Lawrence
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

5.  Considerations in the radiation therapy of Wilms' tumor.

Authors:  J R Cassady; M Tefft; R M Filler; N Jaffe; D Paed; S Hellman
Journal:  Cancer       Date:  1973-09       Impact factor: 6.860

6.  Lymph node invasion and prognosis in nephroblastoma.

Authors:  B Jereb; M F Tournade; J Lemerle; P A Voûte; J F Delemarre; L Ahstrom; R Flamant; R Gérard-Marchant; B Sandstedt
Journal:  Cancer       Date:  1980-04-01       Impact factor: 6.860

7.  Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study.

Authors:  G J D'Angio; N Breslow; J B Beckwith; A Evans; H Baum; A deLorimier; D Fernbach; E Hrabovsky; B Jones; P Kelalis
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

8.  The changing management of Wilms' tumor over a 30-year period. 1949-1978.

Authors:  J W Clouse; P R Thomas; R C Griffith; C A Perez; T J Vietti; B Fineberg
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

9.  [Wilms' tumors: the actual standpoint (author's transl)].

Authors:  P Gutjahr
Journal:  Klin Padiatr       Date:  1981-05       Impact factor: 1.349

Review 10.  [Prognosis of Wilm's tumor in the course of the SIOP trials and studies].

Authors:  N Graf; O Semler; H Reinhard
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.